Exicure, Inc. is a biotech company that has experienced significant stock fluctuations, but its innovative approach and promising pipeline position it for potential long-term success.

Exicure Inc, a clinical-stage biotech firm, has experienced significant stock price fluctuations, highlighting the risks and uncertainties of the biotech sector despite its promising innovative approach to drug development.